9165 Flashcards
(79 cards)
1
Q
RA 9165
A
Comprehensive Dangerous Drugs Act of 2002
2
Q
Comprehensive Dangerous Drugs Act of 2002
A
9165
3
Q
9165
Approved on
by
A
June 7, 2002
Gloria Macapagal-Arroyo
4
Q
Repealed
A
RA 6425 or the Dangerous Drugs Act of 1972
5
Q
State Policy:
A
safeguard the integrity of its territory and the well-being of its citizenry, particularly the youth, from the harmful effects of dangerous drugs
6
Q
Contains___ articles and____ sections
A
13
102
7
Q
Stiffer penalties for
A
drug traffickers, financiers, syndicates, and public officials involved in illicit drugs
8
Q
Integrated system of planning, implementation, and enforcement of anti-drug abuse policies, projects, and programs
A
9165
9
Q
Mean age -
Median -
Male to female ratio -
A
32
33
9:1
10
Q
DOMINANT DRUGS IN THE PHILIPPINE MARKET
A
Methamphetamine hydrochloride or ‘shabu
Marijuana
Ecstasy
Methylenedioxymethamphetamine
11
Q
Methamphetamine hydrochloride or ‘shabu’
Other names
A
‘poor man’s cocaine’, S, shabs, siopao, sha, ice
12
Q
Marijuana
Other names
A
‘mary jane’, joint, dope, pot, damo, flower
13
Q
Ecstasy
Methylenedioxymethamphetamine (MDMA)
Other names
A
XTC, Adam, essence, E, Molly
14
Q
White odorless crystals/powder with a bitter numbing taste
A
Shabu
15
Q
May be ingested, inhaled, sniffed, injected, or smoked
A
Shabu
16
Q
Causes anxiety, irritability, irrational behavior
Long-term use: psychosis, difficulty in concentrating, formication (sensation of bugs)
A
Shabu
17
Q
Marijuana
Comes from the plant
A
Cannabis sativa
18
Q
Smoked in pipes, made into candy, taken as food, sniffed in powder
A
Marijuana
19
Q
Causes fast heartbeat, bloodshot eyes, dry mouth
Early use: stimulant,
later use: depressant
Detected in the lab by its metabolite, THC or tetrahydrocannabinol
A
Marijuana
20
Q
Causes exaggerated emotions, increased heart rate and blood pressure, dry mouth, chills, sweating, nausea, promotion of trust and closeness
A
Ecstasy
21
Q
Marijuana
Window detection
Initial
Confirmatory
A
2 days to 3 weeks
50
15
22
Q
Methamphetamine
Window detection
Initial
Confirmatory
A
2-3
500
250
23
Q
Amphetamine
Window detection
Initial
Confirmatory
A
2-3 days
1000
250
24
Q
Cocaine
Window detection
Initial
Confirmatory
A
2-3 days
300
100
25
NRL Rule in methamphetamine analysis:
POSITIVE: if meth level is >_____ ng/mL AND amphetamine level is >_____ ng/mL
>250
>100
26
_________
develop, promote and implement a national drug abuse prevention program in the workplace to be adopted by private companies with______ or more employees
mandatory drafting and adoption of company policies against drug use in the workplace
DRUG-FREE WORKPLACE
ten (10) or more employees
27
shall appropriate a substantial portion of their respective annual budgets to assist in or enhance the enforcement of this Act giving priority to preventive or educational programs and the rehabilitation or treatment of drug dependents
LOCAL GOVERNMENT UNIT
28
: Any place or premises which have been used on ____ or more
occasions as the site of the unlawful sale or delivery of dangerous drugs
Public nuisance
two (2) or more
29
A drug dependent or drug user may apply for treatment and rehabilitation of the drug dependency
VOLUNTARY SUBMISSION
30
VOLUNTARY SUBMISSION
Rehabilitation period:________ (appraisal of further confinement must be done after)
After-care and follow-up program for at least______ months after discharge
not less than 6 months and not more than 1 year (6months-1yr)
18 months
31
The policy-making and strategy-formulating body in the planning and formulation of policies and programs on drug prevention and control
DANGEROUS DRUGS BOARD
32
DANGEROUS DRUGS BOARD
____members:____ permanent,____ ex-officio,___ regular
17
3
12
2
33
DDB
_____permanent members
1 chairman: 6 years term
____members: 6 years term
3
2
34
To carry out the provisions of RA 9165
PHILIPPINE DRUG ENFORCEMENT AGENCY
35
PHILIPPINE DRUG ENFORCEMENT AGENCY
1_________, 2 _______ (1 for ______; 1 for _______)
Director-General
Deputies Director General
(1 for Administration, 1 for Operations)
36
_________
recruitment and training of all PDEA agents and personnel
at least ________ years old, of proven integrity and honesty and a_______ degree holder
PDEA Academy
twenty-one (21)
Baccalaureate
37
Drug Testing
Mandatory
driver's and firearms license applicants
law enforcers
public officers*
RA 9165 violators
convicted of a crime with more than 6 years imprisonment*
38
Drug Testing
Random
Employees (government and private),
students (secondary and tertiary)
39
RA ______removed the mandatory drug testing for applicants for drivers' license
Only mandatory if the law enforcement officer has probable cause to believe that a person is driving under the influence of dangerous drugs and/or other similar substances
RA 10586
40
Drug Testing Facilities
Screening: at least_____ sq.m. floor area with a_____ sq.m. working area
Confirmatory: at least___ sq.m. floor area with a____ sq.m. working area
can accommodate at least____ patients at one time
hand washing area, toilet stalls
Screening: 20; 10
Confirmatory: 60; 30
5 patients
41
Specimen Collection
Must be at a permanent drug testing facility (except for remote collection which is allowed in the following:
Workplace/school/jail or prison/rehabilitation center
Persons who are critically-ill or disabled
In these cases, sample validity tests must be performed
42
Specimen collection
Must be at a permanent drug testing facility (except for remote collection which is allowed in the following:
Workplace/school/jail or prison/rehabilitation center for:
Random
Follow-up
Reasonable suspicion/cause
Crime scene and post-accident
43
HEAD OF THE LAB (Screening)
Clinical Pathologist or any licensed physician w/ certification in_________ by the DOH
______: maximum screening labs a physician can handle (within 5 km radius)
Clinical Laboratory Management
10
44
HEAD OF THE LAB (Confirmatory)
physician/pathologist with_____ years experience in analytical toxicology
chemist with a______ degree and ____ years experience in analytical chemistry
2 yrs experience in analytical toxicology
master's degree
2 years experience in analytical chemistry
45
ANALYST (Screening)
either a chemist
med tech
pharmacist
or chemical engineer with training
46
ANALYST (Confirmatory)
Required:
The personnel verify chain of custody, perform test, certify results, perform QA
full-time chemist with training in chromatography and mass spectroscopy and either a
med tech
pharmacist
or chemical engineer with training in screening
47
instructs, assists, and receives/inspects specimens
AUTHORIZED SPECIMEN COLLECTOR
48
A BHFS-approved form used to document the collection, transport, security, and test results of the specimen
donor's info
CoC document
status of specimen: temperature, appearance
drug test requested
result of test
Custody and Control Form
49
The form/s used to document the security of the specimen and all aliquots of the specimen during testing and storage
Includes the names and signatures of all individuals who handled the specimen and the date and purpose of access
Chain of Custody Document
50
DRUG TESTING SPECIMENS
Urine
Saliva
Blood
Hair
Sweat
51
: most common (easiest specimen to collect)
URINE
52
Urine
______ mL is needed prolonged storage at (-20 degrees C)
collected in a 30-60 mL_____ specimen container
60 mL
polyethylene
53
Saliva
______ mL of saliva collected in a ____ mL polyethylene specimen container
2 mL
30 mL
54
Specimen
most expensive, most accurate
Blood
55
Blood
plain test tube,_____ mL (sample: minimum of_____ mL)
No standardized procedure available
10 mL
5 mL
56
Sweat
FDA-approved sweat patch (worn _____)
1-2 weeks
57
Hair
_____mg hair in _____mg capacity self-sealing transparent plastic bag
expensive and tedious
100 mg
200 mg
58
detects chronic substance abuse
Hair
59
SPECIMEN HANDLING
Ensure the integrity of urine specimen
______agents in toilet bowl
Removal of unnecessary outer garments, body search
Washing and drying of hands prior to urination
Checking urine (4)
Coloring agents
volume, temperature, color, and appearance
60
SPECIMEN HANDLING
Labeling of the specimen
Date/time of collection
Signature of client and ASC
Specimen ID number
61
SPECIMEN RETENTION
Negative:_____ days after receipt of result
Positive, adulterated, substituted, or invalid: minimum of_____ days upon receipt of result; may be extended for up to a____ upon request
5
15
year
62
VALIDITY OF SPECIMENS
suspicious/unobserved urine collection
invalid specimens (2)
tampered;
improperly collected, handled, stored, and documented
63
PARAMETERS FOR VALIDITY TEST
Color
Appearance:
Odor:
Volume:
Temperature:_____ degrees C
pH:
Specific Gravity: 1.003-1.030
clear
aromatic
30-60 mL
32-38
4.0-9.0
64
TAMPERING OF SPECIMENS
with a substance not normally present in the test specimen
Addition of juice, illicit drugs
Taking of drug screens like (3) which interfere with drug analysis
'doping samples': adding chemicals to urine
e.g. (4)
ADULTERATION
aspirin, niacin, and zinc sulfate
bleach, ammonia/liquid soap/table salt, hydrogen peroxide, vinegar
65
TAMPERING OF SPECIMENS
less than normal physiological constituents
: plenty of water, diuretics
: adding water to specimen
DILUTION
Internal dilution
External dilution
66
TAMPERING OF SPECIMENS
submission of switched or replaced sample
SUBSTITUTION
67
ANALYTICAL METHODS
Screening
FDA-DOH-approved testing kits using immunoassay
Instrumented screening method
Immunoassay: 2
Chromatographic: 2
ELISA, fluorescence polarization immunoassay
TLC, HPLC
68
ANALYTICAL METHODS
Screening
Competition between free drug and immobilised drug (immobilised antigen) for limited antibodies
In presence of drug, free drug binds to the antibody conjugate, preventing it from binding to immobilised drug. No colour reaction.
If no drug present antibody complex binds to the immobilised drug to produce coloured line
Competitive Assay
69
ANALYTICAL METHODS
Confirmatory
Gold standard:__________
Qualitative chemical characterization
Quantitation and determination of concentration of analyte
gas chromatography-mass spectrometry (GC-MS)
70
: presence or absence of a drug
TAT:_____
Screening test
30mins
71
presence or absence, identity of the metabolite, concentration of the drug
TAT:
Confirmatory test
15 days
72
DRUG TESTING
lab satisfaction for quality validation
***replicate test*** to check the initial test result of same sample
Re-test
73
DRUG TESTING
replicate test when confirmatory results are ***legally questioned***
complainant will pay the test fee
Challenge test
74
Lab Records
(5)
training records
custody and control form
QA records
reports
calculations in test results
75
T or F
drug labs participate in NEQAS
True
76
***License validity***
Screening Lab:
Confirmatory Lab:
1 year
2 years
77
VIOLATIONS
issuance of ***false results***
_____ and _____ of license
___________imprisonment
____________fines
_____, ______of center
suspension and revocation 6 years and
1 day to 12 years
Php 100,000-500,000
revocation of license, closure
78
VIOLATIONS
failure to protect confidentiality
failure to pass proficiency trainings
criminal offense of owner or manager
committed as an incident to the operation of the laboratory
failure to refer positive results
others (reprimand, suspension, revocation)
79
VIOLATIONS
investigator:
BHFS (Bureau of Health Facilities Services)
